"When it reviews new drugs, the FDA must strike a careful balance between safety and speed," said Allan Coukell, director of medical programs for the Pew Health Group, which funded the research.Full Story
Responsible for regulating more than $1 trillion in consumer products, the U.S. Food and Drug Administration (FDA) protects and promotes the nation’s health. The FDA works to ensure the safety and effectiveness of drugs, medical devices, and vaccines, and to facilitate their timely introduction to the marketplace.
When the FDA does its job well, Americans have access to safe and innovative treatments. But when it does not, a variety of threats may arise: approval decisions beset by delays or unnecessary costs can stifle the development of beneficial new products; prematurely approving an ineffective drug or device exposes patients to risks with no demonstrable benefit; inadequately monitoring risk may endanger patients’ health.
Pew backs the FDA’s efforts to utilize the most up-to-date scientific research and technology in support of its mission. To that end, we are working with key stakeholders, including physicians, scientists, businesses, patient advocates and the agency to improve FDA science, predictability, and efficiency.